BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11573060)

  • 1. Resolution of a spontaneous coronary artery thrombus with a new antiplatelet agent.
    Dagdelen S; Soydinc S; Ergelen M; Caglar N
    Int Angiol; 2001 Sep; 20(3):244-7. PubMed ID: 11573060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissolution of a huge spontaneous coronary artery thrombus with a new antiplatelet agent and coronary angioplasty.
    Akdemir R; Uyan C
    Int J Cardiol; 2003 May; 89(1):87-9. PubMed ID: 12727009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombus aspiration plus intra-infarct-related artery administration of tirofiban improves myocardial perfusion during primary angioplasty for acute myocardial infarction.
    Yan HB; Li SY; Song L; Wang J; Wu Z; Chi YP; Zheng B; Zhao HJ; Li QX; Zhang XJ; Li WZ
    Chin Med J (Engl); 2010 Apr; 123(7):877-83. PubMed ID: 20497681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous integrin alphavbeta3 and glycoprotein IIb/IIIa inhibition causes reduction in infarct size in a model of acute coronary thrombosis and primary angioplasty.
    Sakuma T; Sari I; Goodman CN; Lindner JR; Klibanov AL; Kaul S
    Cardiovasc Res; 2005 Jun; 66(3):552-61. PubMed ID: 15914120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of intracoronary thrombus using tirofiban in a patient with normal coronary arteries.
    Ozeren A; Aydin M; Ozkökeli M; Unalacak M; Bilge M
    Jpn Heart J; 2004 Mar; 45(2):343-6. PubMed ID: 15090712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive therapies in the cath lab. Intracoronary tirofiban infusion in a case with massive intracoronary thrombus.
    Timurkaynak T; Cemri M; Ozdemir M; Yalçin R; Cengel A; Dörtlemez O
    J Invasive Cardiol; 2001 Sep; 13(9):654-6. PubMed ID: 11533506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and efficacy of glycoprotein IIb/IIIa therapy for treatment of threatened or acute vessel closure in 1332 patients undergoing percutaneous transluminal coronary angioplasty.
    Haase KK; Mahrholdt H; Schröder S; Baumbach A; Oberhoff M; Herdeg C; Karsch KR
    Am Heart J; 1999 Feb; 137(2):234-40. PubMed ID: 9924156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
    Cannon CP; Weintraub WS; Demopoulos LA; Vicari R; Frey MJ; Lakkis N; Neumann FJ; Robertson DH; DeLucca PT; DiBattiste PM; Gibson CM; Braunwald E;
    N Engl J Med; 2001 Jun; 344(25):1879-87. PubMed ID: 11419424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A safety and feasibility report of combined direct thrombin and GP IIb/IIIa inhibition with bivalirudin and tirofiban in peripheral vascular disease intervention: treating critical limb ischemia like acute coronary syndrome.
    Allie DE; Hebert CJ; Lirtzman MD; Wyatt CH; Keller VA; Khan MH; Khan MA; Fail PS; Vivekananthan K; Allie SE; Mitran EV; Chaisson G; Stagg SJ; Allie AA; McElderry MW; Barker EA; Walker CM
    J Invasive Cardiol; 2005 Aug; 17(8):427-32. PubMed ID: 16079449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased reperfusion by glycoprotein IIb/IIIa receptor antagonist administration in case of unsuccessful and failed thrombolysis in patients with acute myocardial infarction: a pilot study.
    Di Pasquale P; Sarullo FM; Cannizzaro S; Vitrano MG; Giubilato A; Scalzo S; Giambanco F; Paterna S
    Ital Heart J; 2001 Oct; 2(10):751-6. PubMed ID: 11721719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial.
    Valgimigli M; Campo G; Percoco G; Bolognese L; Vassanelli C; Colangelo S; de Cesare N; Rodriguez AE; Ferrario M; Moreno R; Piva T; Sheiban I; Pasquetto G; Prati F; Nazzaro MS; Parrinello G; Ferrari R;
    JAMA; 2008 Apr; 299(15):1788-99. PubMed ID: 18375998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of coronary stent thrombosis in patients treated with prophylactic tirofiban.
    Assali AR; Sdringola S; Ghani M; Westbrook LA; Anderson HV; Schroth G; Fujise K; Smalling RW; Rosales OR
    J Invasive Cardiol; 2000 Sep; 12(9):460-3. PubMed ID: 10973371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glycoprotein IIb/IIIa platelet blockers in acute myocardial infarct treated with primary coronary angioplasty].
    Kala P; Poloczek M; Bocek O; Jerábek P; Neugebauer P; Kosová J; Semrád B
    Vnitr Lek; 2002 Aug; 48(8):736-41. PubMed ID: 12425204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healing of spontaneous coronary dissection in the context of glycoprotein IIB/IIIA inhibitor therapy: a case report.
    Cheung S; Mithani V; Watson RM
    Catheter Cardiovasc Interv; 2000 Sep; 51(1):95-100. PubMed ID: 10973029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A patient with an extensive coronary artery thrombus.
    Chalikias G; Kikas P; Thomaidis A; Serif L; Georgiadis GS; Tziakas D
    Hellenic J Cardiol; 2018; 59(6):347-348. PubMed ID: 29126949
    [No Abstract]   [Full Text] [Related]  

  • 16. Images in cardiology. Glycoprotein IIb/IIIa induced coronary thrombolysis.
    Bickel C; Henkel B; Fallen H
    Heart; 2002 May; 87(5):442. PubMed ID: 11997416
    [No Abstract]   [Full Text] [Related]  

  • 17. [The clinical use of the GPIIb/IIIa inhibitors eptifibatide and tirofiban in the treatment of acute coronary syndromes of the "non-ST elevation" type].
    Galli M; Maggioni AP; Vassanelli C; Tavazzi L
    Ital Heart J Suppl; 2000 Feb; 1(2):202-11. PubMed ID: 10731377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late coronary stent thrombosis associated with exercise testing.
    Parodi G; Antoniucci D
    Catheter Cardiovasc Interv; 2004 Apr; 61(4):515-7. PubMed ID: 15065149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lysis of an intracoronary thrombus with a glycoprotein IIb/IIIa antagonist].
    Ammann P; Naegeli B; Schuiki E; Bertel O
    Schweiz Med Wochenschr; 2000 Mar; 130(9):336. PubMed ID: 10746274
    [No Abstract]   [Full Text] [Related]  

  • 20. Additive benefit of glycoprotein IIb/IIIa inhibition and adjunctive thrombus aspiration during primary coronary intervention: results of the Initial Thrombosuction and Tirofiban Infusion (ITTI) trial.
    Liu CP; Lin MS; Chiu YW; Lee JK; Hsu CN; Hung CS; Kao HL
    Int J Cardiol; 2012 Apr; 156(2):174-9. PubMed ID: 21131072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.